Rocket Doctor AI Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Essam Hamza
- Full Time Employees
- 3
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 800 – 885 West Georgia Street Vancouver BC Canada V6C 3H1
- IPO Date
- Apr 19, 2021
- Website
- rocketdoctor.ai
- Similar Companies
- Business
- Rocket Doctor AI Inc. (CSE: AIDR) develops and provides AI-powered healthcare technology solutions, including its proprietary Global Library of Medicine (GLM), an AI-driven clinical knowledge engine that delivers diagnostic support, recommended tests, imaging, and billing codes with over 92% first-diagnosis accuracy; the Rocket Doctor digital health platform and marketplace, which enables physicians to manage practices through video consultations, prescriptions, lab requisitions, patient records, and paperwork automation; the Medical Education Suite (MES) for AI-enhanced clinical training and assessments; RD AI Connect for auto-triaging patient complaints; RD AI Health Voyager for patient history summaries; AI-Voice Nurse for care support and mental health access; and open APIs, chatbots, and voice AI tools for integration into virtual care systems. The company targets healthcare professionals, physicians, medical and nursing schools, health systems, and patients seeking personalized symptom assessment, wellness management, and equitable care in underserved communities, operating primarily in North America with expansion into the Middle East. Founded in 2016 and formerly known as Treatment.com AI Inc., Rocket Doctor AI Inc. is headquartered in Vancouver, British Columbia, Canada, with additional offices in Calgary and Moncton (Canada), Minneapolis (U.S.), and other U.S. locations; it operates through subsidiaries including Rocket Doctor Inc. and maintains a presence via wholly owned entities focused on personalized healthcare AI. In November 2025, the company entered into a definitive agreement to acquire Alea Health Holdings Ltd., adding AI-powered mental health services, telemedicine, patient intake software, and a foothold in the UAE market to integrate mental health with primary care and support global expansion; recent U.S. growth includes new payer contracts, virtual emergency department diversion models, and revenue from AI solutions comprising about 5% of 2024 totals, alongside strong Q3 2025 momentum from commercialization efforts.
Company News
Rocket Doctor AI to Present at the 153rd National Investment Banking Association (NIBA) Conference in Florida
Rocket Doctor AI Inc. (AIRDF) Discusses Strategic Overview and Growth Plans for U.S. and Canada Transcript
Rocket Doctor AI Provides Operational Update for U.S. Operations for First Two Months of Q3 2026 Ahead of Global Company Town Hall
Rocket Doctor AI Announces Global Company Town Hall to Showcase Q2 2026 Milestones and Strategic Vision
Rocket Doctor AI Reports Strong Operational Momentum in Q2 2026 Driven by U.S. Expansion and Growing Patient Reach
Rocket Doctor Grants Equity
Rocket Doctor Enters New Strategic Network Agreement in California to Expand Access Across Multiple U.S. Healthcare Channels
Rocket Doctor AI Inc. Announces Non-Brokered Private Placement of Unsecured Convertible Debentures
Rocket Doctor Named One of Canada's Top 100 AI & Tech Startups for ALL IN 2026
Rocket Doctor Joins National Coalition Advocating for Permanent Medicare Telehealth
Rocket Doctor AI Inc. Appoints Financial Growth Strategist Andrew Lau as Chief Financial Officer to Help Accelerate U.S. Expansion
Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members
Rocket Doctor Partners with Mindstride to Expand Access to After-Hours Healthcare Across Ontario, Alberta and British Columbia
Rocket Doctor Grants Stock Options and RSUs
Rocket Doctor Grants Stock Options and RSUs
Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision
Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision
Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation
Rocket Doctor Inc. Selected to Join Canadian Life Sciences Trade Mission to New York and New Jersey
Rocket Doctor Amends 45 Degree Agreement